Europe Pharma News 4/4

top of page

Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit

ipharmaservices

Jun 7, 2020

#EULAR2020

ipharmaservices

Jun 4, 2020

Sanofi’s Sarclisa approved in Europe for relapsed and refractory multiple myeloma

ipharmaservices

Jun 3, 2020

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

ipharmaservices

Jun 3, 2020

European Commission approved Zolgensma, activates “Day one” access program

ipharmaservices

May 19, 2020

HAS gave favorable opinion for reimbursing Darzalex for treating multiple myeloma naïve patients

ipharmaservices

May 17, 2020

EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

ipharmaservices

May 17, 2020

PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

ipharmaservices

May 10, 2020

Novo Nordisk’s Rybelsus approved by European Union

ipharmaservices

Apr 5, 2020

NICE recommendation to manage symptoms of COVID-19

NICE recommendation to manage symptoms of COVID-19

NICE recommendation to manage symptoms of COVID-19

ipharmaservices

Apr 4, 2020

EMA approved GSK’s Trelegy Ellipta for asthma

EMA approved GSK’s Trelegy Ellipta for asthma

EMA approved GSK’s Trelegy Ellipta for asthma

ipharmaservices

Feb 28, 2020

EMA approved Mayzent (siponimod) for secondary progressive multiple sclerosis

ipharmaservices

Jan 27, 2020

European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA

European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA

European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA

ipharmaservices

Dec 20, 2019

CHMP gave positive opinions for Beovu and Recarbrio

ipharmaservices

Dec 17, 2019

bottom of page